Genentech News

Monogram Biosciences Inc. said Tuesday that it will make its HERmark breast cancer assay available to doctors throughout the United States starting July 15.

The Food and Drug Administration on Tuesday approved a new genetic test from Invitrogen Corp.

Drug stocks were mixed in early action Monday as shares of Genentech Inc. lost ground following a weekend story in The New York Times that questioned whether the benefits of its highly-touted cancer drug ...

The San Mateo County Board of Supervisors on Thursday scheduled a closed-door session to tackle a staggering $20 million debt that came to light earlier this week.

Department of Molecular, Cellular, and Developmental Biology, Yale University, 266 Whitney Avenue, New Haven, CT 06520, USA 2 Interdisciplinary Neuroscience Program and Department of Cell Biology, Yale ...

When you're developing a cure for cancer, a sense of urgency is important. But combine that intense sense of mission with an informal, nonhierarchical workplace that offers plenty of perks, and you've got ...

Leonard Downie, Jr., who has served as executive editor of The Washington Post since September 1, 1991, has decided to retire in the fall of 2008.

Column Group seeks 'pipeline of products' San Francisco Business Times - by Ron Leuty Rick Klausner is looking for the next Genentech .

The 13-year Human Genome Project, which got under way in late 1990, stirred visions of finding cures to devastating diseases and creating therapy personalized for individual patients based on genetic and ...

On the one hand, you'll likely never find anything so aptly named in finance. It is indeed a beige book.

Genentech Inc. said Wednesday it settled a patent dispute with MedImmune Inc. over the so-called "Cabilly" patent.

In response to the rise of oil prices Virgin America has announced fuel surcharges in all of its markets, effective immediately.

Silicon Valley / San Jose Business Journal - by Ron Leuty A startup in San Mateo that makes therapeutic proteins and antibodies raised $21 million in financing and netted a broad partnership with an Indian ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Seattle Genetics, Inc. today announced final data from the phase I clinical trial of SGN-40 in patients with relapsed or refractory non-Hodgkin lymphoma.

Drug stocks edged modestly higher in early action Tuesday while shares of Genentech Inc.

Genentech, Inc. today announced that Avastin , in combination with docetaxel chemotherapy, significantly increased the time women with metastatic breast cancer receiving first-line therapy lived without their ...

Genentech Inc. said Saturday that a second Phase III study showed its drug Avastin can stop the progression of metastatic breast cancer when combined with chemotherapy.

The addition of Genentech Inc's cancer drug Avastin to chemotherapy slows the progress of breast cancer, according to results of a large international trial released on Saturday.

The biotechnology industry has yet to turn a profit but investors are pouring billions into the development of genetically engineered drugs needed by major pharmaceutical companies to reinvigorate their product ...